insights_auto
Why is GOVX down 5.56%?
Dive Deeperchevron_right
GOVX:NASDAQ
Geovax Labs Inc
$2.04
arrow_downward
-5.56%(-0.12) 1D
$2.20
arrow_upward
+7.84% (+0.16)todayPre-market
Closed: Nov 12, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$2.10
High
$2.18
Low
$1.94
Mkt. cap
18.95M
Avg. vol.
50.18K
Volume
12.58K
52-wk high
$311.94
52-wk low
$1.84
EPS
-$13.92
Beta
3.85
Shares outstanding
509.00K
No. of employees
19
Open
$2.10
High
$2.18
Low
$1.94
Mkt. cap
18.95M
Avg. vol.
50.18K
Volume
12.58K
52-wk high
$311.94
52-wk low
$1.84
EPS
-$13.92
Beta
3.85
Shares outstanding
509.00K
No. of employees
19
News stories
From web sources and news partners
Investing.com Canada
·
23 hours ago
GeoVax Labs enacts 1-for-24 reverse stock split on Nasdaq Capital Market
Investing.com Canada
·
23 hours ago
Form 8K GeoVax Labs Inc For: 12 November By Investing.com
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegeovax.com